Clinical Case Studies: ULTRA
The ULTRA Embolic Device is being clinically evaluated for use in embolization to control bleeding in the peripheral vasculature and hypervascular tumors.
Angiomyolipoma Tumor
ULTRA was used to embolize the feeding vessels to a large AML tumor arising from the left kidney. Follow-up imaging at 43 days post treatment confirmed the stability of the device. No adverse events were observed.
Renal Cell Carcinoma Tumor
ULTRA was used to embolize a large, renal cell carcinoma tumor prior to nephrectomy.
03
Project Name
This is your Project description. Provide a brief summary to help visitors understand the context and background of your work. Click on "Edit Text" or double click on the text box to start.
04
Project Name
This is your Project description. Provide a brief summary to help visitors understand the context and background of your work. Click on "Edit Text" or double click on the text box to start.
